首页> 外文期刊>臨床血液 >Simultaneous development of factor V inhibitor and autoimmune thrombocytopenia in a patient with dermatomyositis
【24h】

Simultaneous development of factor V inhibitor and autoimmune thrombocytopenia in a patient with dermatomyositis

机译:皮肌炎患者同时发展V因子抑制剂和自身免疫性血小板减少

获取原文
获取原文并翻译 | 示例
       

摘要

It has been previously demonstrated that aging, a history of malignancy or surgery, and exposure to bovine thrombin may be related to the presence of factor V inhibitor. However, dermatomyositis (DM) and autoimmune thrombocytopenic purpura (ATP) have rarely been associated with factor V inhibitor. Here we report a patient with factor V inhibitor accompanied by DM and ATP. In January 2000, a 77-year-old woman with DM was hospitalized because of susceptibility to bleeding. At the onset of DM, she had suffered from gastric leiomyosarcoma, and had undergone gastrectomy and splenectomy without the use of bovine thrombin. Thereafter, she had been treated with prednisolone until October 1999. On admission, prolongation of both APTT and PT was seen. Her factor V activity had fallen to 6%, and factor V inhibitor was positive at 8.9 Bethesda units. Moreover her platelet count had dropped to 1.0 x 10(9)/l. A bone marrow aspirate showed a cellular marrow with megakaryocytic hyperplasia, and the patient's PA-IgG level was elevated at 389 ng/10(7) cells. These findings suggested that ATP was also present. Additionally, the patient showed a positive result for Coombs test and consumption of complement. After a further course of steroid therapy, the patient's condition was markedly improved. This is a very rare case that showed factor V inhibitor and ATP simultaneously. Furthermore, the patient's clinical course suggests the relationship between the presence of factor V inhibitor and the reactivation of her collagen disease activity.
机译:先前已证明衰老,恶性肿瘤或手术史以及暴露于牛凝血酶可能与V因子抑制剂的存在有关。然而,皮肌炎(DM)和自身免疫性血小板减少性紫癜(ATP)很少与V因子抑制剂相关联。在这里,我们报告了伴有DM和ATP的V因子抑制剂患者。 2000年1月,一名77岁的DM妇女因容易出血而住院。在DM发作时,她患有胃平滑肌肉瘤,并且在未使用牛凝血酶的情况下进行了胃切除术和脾切除术。此后,她一直接受泼尼松龙治疗,直到1999年10月。入院时,APTT和PT均延长。她的V因子活性下降到6%,V因子抑制剂在8.9 Bethesda单位上呈阳性。此外,她的血小板计数已降至1.0 x 10(9)/ l。骨髓穿刺液显示具有巨核细胞增生的细胞,患者的PA-IgG水平升高至389 ng / 10(7)个细胞。这些发现表明ATP也存在。另外,该患者在Coombs测试和补体消耗方面显示出阳性结果。经过进一步的类固醇治疗后,患者的病情明显改善。这是极少见的同时显示因子V抑制剂和ATP的情况。此外,患者的临床病程表明因子V抑制剂的存在与其胶原疾病活性的重新激活之间存在关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号